Ontology highlight
ABSTRACT: Background
Using change in estimated glomerular filtration rate (eGFR) based on creatinine concentration as a surrogate outcome in clinical trials of chronic kidney disease has been proposed. Risk for end-stage renal disease (ESRD) and all-cause mortality associated with change in concentrations of other filtration markers has not been studied in chronic kidney disease populations.Study design
Observational analysis of 2 clinical trials.Setting & participants
Participants in the MDRD (Modification of Diet in Renal Disease; n=317) Study and AASK (African American Study of Kidney Disease and Hypertension; n=373).Predictors
Creatinine, cystatin C, β-trace protein (BTP), and β2-microglobulin (B2M) were measured in serum samples collected at the 12- an
SUBMITTER: Rebholz CM
PROVIDER: S-EPMC5610931 | biostudies-literature | 2017 Oct
REPOSITORIES: biostudies-literature